<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04716517</url>
  </required_header>
  <id_info>
    <org_study_id>381020</org_study_id>
    <nct_id>NCT04716517</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult With Class V Carious</brief_title>
  <official_title>Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult Patients With Class V Carious Lesions Over One Year Period: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cention N will have the same clinical performance as resin-modified glass ionomer in cervical&#xD;
      carious lesions. Evaluation of restorations will be done at baseline, six months, and one&#xD;
      year according (USPHS) criteria.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, Class V carious lesions were restored using two different restorative&#xD;
      materials either resin modified glass ionomer or Cention N restorative materials. This study&#xD;
      will be held in the restorative clinic at Future University in Egypt. Patients will be&#xD;
      assessed for medical and dental histories first. Then an examination of the patients will be&#xD;
      done using visual inspection by using a dental mirror and probe. Eligible patients according&#xD;
      to inclusion and exclusion criteria will be informed about all procedures with follow up time&#xD;
      if they accept, 12 their signature on written informed consents will be obtained. Eligible&#xD;
      participants will be randomly divided into two groups according to the type of restoration&#xD;
      they will be received. The first group (A) will be received resin modified glass ionomer&#xD;
      restorative material and the second group (B) will be received Cention N restorative&#xD;
      materials. Each restoration will be evaluated for clinical parameters after finishing and&#xD;
      polishing at baseline and regular recalls of 6 months and one year.&#xD;
&#xD;
      The restorations will be clinically examined according to modified USPHS criteria in terms of&#xD;
      marginal adaptation, anatomic form, color match, marginal discoloration, secondary caries,&#xD;
      postoperative sensitivity and retention. The information that will be obtained will be&#xD;
      collected and statistically analyzed&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>(Marginal adaptation)</measure>
    <time_frame>12 months</time_frame>
    <description>(USPHS) criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical performance (Anatomical form, Secondary caries, marginal discoloration, Postoperative sensitivity, Color match, Retention)</measure>
    <time_frame>12 months</time_frame>
    <description>(USPHS) criteria</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Cervical Lesion</condition>
  <arm_group>
    <arm_group_label>Cention N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Alkasite Restoration will be used to restore cervical carious in adult patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resin Modified Glass Ionomer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparator Resin-modified glass ionomer material will be used to restore cervical carious in adult patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alkasite bioactive restorative material.</intervention_name>
    <description>Alkasite restorative is a category of filling material, like compomer, and is essentially a subgroup&#xD;
of the composite resin. Cention N is a urethane dimethacrylate (UDMA)-based, self-curing powder/liquid restorative with optional additional light curing. The liquid comprises of dimethacrylates and initiators, while the powder contains various glass fillers, initiators, and pigments. It is radio opaque and contains alkaline glass fillers capable of releasing fluoride, calcium, and hydroxide ions. Due to the sole use of cross-linking methacrylate monomers in combination with a stable, efficient self-cure initiator, Cention N displays a high polymer network density and degree of polymerization over the complete depth of the restoration.</description>
    <arm_group_label>Cention N</arm_group_label>
    <other_name>(Cention N).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resin Modified Glass Ionomer</intervention_name>
    <description>The resin-modified glass ionomer materials are hybrid materials of traditional glass ionomer cement with a small addition of light-curing resin, and hence exhibit properties intermediate to the two, with some characteristics superior to conventional glass ionomer materials</description>
    <arm_group_label>Resin Modified Glass Ionomer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients with High caries risk.&#xD;
&#xD;
          -  Patients with poor oral hygiene.&#xD;
&#xD;
          -  Patients with untreated cervical caries lesion.&#xD;
&#xD;
          -  patient aging â‰¥18 years.&#xD;
&#xD;
          -  Absence of tooth mobility&#xD;
&#xD;
          -  Absence of abnormal occlusion.&#xD;
&#xD;
          -  Patients with good likelihood of recall availability.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients with cervical caries lesions need crown restoration.&#xD;
&#xD;
          -  Non-vital teeth.&#xD;
&#xD;
          -  Evidence of parafunctional habits.&#xD;
&#xD;
          -  Teeth supporting removable prosthesis.&#xD;
&#xD;
          -  Periapical Abscess or Fistula.&#xD;
&#xD;
          -  Patients with systemic disease.&#xD;
&#xD;
          -  Patients with xerostomia.&#xD;
&#xD;
          -  Participants with a history of allergy to any component of restorations will be used&#xD;
             in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>hadeel alsalamony</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Expecting to have all the data by October 2022</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

